FATE 2.22 (+1.83%)
US31189P1021BiotechnologyBiotechnology

Fate Therapeutics (FATE) Financial Metrics

This table shows a selected set of financial data points of Fate Therapeutics (FATE). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.64 0 -2.29 368.06M -0.27 63.53M -138.42M -174.74M -160.93M 41.87M
2022 -2.91 0 -3.47 976.97M -0.35 96.3M -283.77M -314.94M -281.72M 61.33M
2021 -2.24 0 -26.13 5.54B -0.27 55.85M -213.57M -214.68M -212.15M 133.58M
2020 -2.1 0 -43.21 7.49B -0.38 31.43M -44.16M -77.3M -173.39M 167.35M
2019 -1.44 0 -13.6 1.33B -0.38 10.68M -90.57M -96.4M -98.15M 99.81M
2018 -1.19 0 -10.83 720.99M -0.42 4.74M -40.95M -63.7M -66.6M 190.51M
2017 -1.02 0 -5.97 256.51M -0.43 4.11M -38.63M -40.71M -42.95M 88.95M
2016 -1.05 0 -2.38 79.7M -0.41 4.4M -30.28M -30.94M -33.46M 88.61M
2015 -1.18 0 -2.86 85.88M -0.5 2.43M -19.9M -27.09M -29.99M 64.81M
2014 -1.27 0 -3.97 102.87M -0.48 0 -23.3M -24.84M -25.88M 49.1M
2013 -3.54 0 -1.77 37.03M -0.63 971K -15.62M -19.53M -20.89M 54.04M
2012 -1.91 0 0 0 -1.5 2.67M -13.98M -13.16M -14.24M 9.09M
2011 -1.51 0 0 0 0 1.17M -12.15M -12.63M -13.43M 6.39M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.